Novo Nordisk on Sunday said full results from two late-stage trials of its experimental weight-loss drug CagriSema show that ...

Overweight patients given an experimental weight loss drug being developed by China's Sciwind Biosciences lost an average of ...

Some new medications in development are also trying to solve for a persistent side effect of existing drugs: Patients who ...

Novo Nordisk on Friday said full results from early-stage trials show that its experimental drug, amycretin, helped ...

GLP-1 drugs like Ozempic help with weight loss, but how do they stack up against bariatric surgery? A new study breaks it ...

Patients on GLP-1 medications lost about half as much weight as participants did in clinical trials, NYU researchers found.

While the makers of Ozempic have stated that its GLP-1 medication was not made to be used as a weight loss drug, nor should ...

A new study reports that people taking GLP-1 drugs in daily life don’t lose as much weight as those in clinical trials who ...

Ozempic is an FDA-approved medication for people with type 2 diabetes. It’s often prescribed off-label for weight loss — that ...

A trial pitting weight loss jab Mounjaro against competitor Wegovy ended with one clear winner, and Mounjaro is getting ...

This would make amycretin a more effective than other weight loss drugs like Wegovy, where a trial found that patients lost ...